Peixun Zhou - Concepedia

Author

Peixun Zhou

Newcastle University ORCID

Also Known As

P Zhou, Peixun Zhou, Pingxin Zhou, Zhou Peixun

Publications

265

Citations

H-Index

Concepts

All Affiliations

Newcastle University Teesside University Northumbria University Newcastle upon Tyne Hospitals NHS Foundation Trust Heidelberg University

About

Peixun Zhou is an author at Newcastle University specializing in stem cell therapies, stem cell research, and stem cells.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	54
2	Health Sciences	1	1	19
3	Biomedical Engineering	1	1	35
4	Cell Biology	1	1	19
5	Pharmacology	1	1	35

Peixun Zhou

Publications

253

Citations

H-Index

Page 1

	Year	Citations
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis Chun Gong, Joanna A. Krupka, Jie Gao, Molecular Cell	2021	86
Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma Alexander M. Newman, Masood Zaka, Peixun Zhou, Leukemia	2021	45
Uptake of synthetic Low Density Lipoprotein by leukemic stem cells — a potential stem cell targeted drug delivery strategy Peixun Zhou, Sophia Hatziieremia, Moira A. Elliott, Journal of Controlled Release Cell-based Drug DeliveryDrug TargetingPotential Stem CellMedicineDrug Delivery Strategy	2010	35
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif Peixun Zhou, Alex E. Blain, Alexander M. Newman, Blood Advances	2019	30
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia Deepali Pal, Helen J. Blair, Jessica Parker, Cell Reports Medicine Mixed-phenotype Acute LeukemiaBlast ProliferationLeukemia CellsStem Cell BiologyCancer Biology	2022	19
Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia Carmela Ciardullo, Katarzyna Szołtysek, Peixun Zhou, Cancers	2021	14
DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia Katarzyna Szołtysek, Carmela Ciardullo, Peixun Zhou, International Journal of Molecular Sciences	2020	13
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development Marina Danilenko, Masood Zaka, Claire Keeling, Acta Neuropathologica	2022	11

Page 1